CClinicalTrials.gg
CompletedNCT02888288Updated Oct 7, 2022

Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth

An interventional study of Mental Health Intervention and Standard of Care in Health Behavior, HIV and Mental Health, sponsored by Duke University. Completed at 1 site in Tanzania. Open to participants aged 12 Years to 24 Years. Per ClinicalTrials.gov, last updated 2022-10-07.

Sponsored by Duke University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
12 Years to 24 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate if a group-based mental health intervention called Sauti ya Vijana (The Voice of Youth) designed to address mental health challenges faced by adolescents in Tanzania is acceptable and feasible and if it improves mental health, antiretroviral therapy (ART) adherence, and virologic outcomes among HIV-positive adolescents as compared to youth receiving treatment as usual. Mental health intervention sessions will take place three times a month for approximately four months in groups of eight to ten youth based on age and sex. Caregivers will attend two sessions to support the youth and provide the guardian perspective on caring for HIV-positive adolescents. The investigator hypothesizes the mental health intervention will be acceptable, feasible, and will improve mental health and ART adherence among participating youth and this improvement will be sustained over time.

Read the detailed description

The study will enroll up to approximately 130 participants from the established Kilimanjaro Christian Medical Centre and Mawenzi Saturday Teen Clinics. Participants will be assigned to approximately eight to ten persons per group, based on age and sex. Groups will be matched in pairs as closely as possible (ex. two groups of females 12-16 years of age) and assigned to Wave 1, 2, or 3. Randomization will occur on the individual level and will occur just before the start of mental health intervention for each wave. Individuals will be randomized at this time point to reduce potential drop out of those with delayed start (Wave 2/3). Randomization will occur by a coin flip for two individuals based on alphabetical order: heads will be intervention group (I) and tails the standard of care group (SOC).

This feasibility study is longitudinal with up to 24 month follow-up after intervention. Feasibility measures from lay counselors will be monitored weekly. Outcome measures will be obtained by blinded interviewers using a structured survey to inquire about mental health symptoms, self-report adherence, obtain an ART drug concentration level from a hair sample, and HIV-1 viral load from a blood sample and will be collected by the same research assistants at five to six potential time points: 1) baseline, 2) pre-intervention, 3) post-intervention, 4) 6-months post-intervention, 5) 12-months post-intervention and 6) 24-months post-intervention.

02

Conditions studied

  • Health Behavior
  • HIV
  • Mental Health

Keywords

  • adolescent
  • adolescence
  • HIV/AIDS
  • mental health
  • cognitive behavioral therapy
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Youth between the ages of 12 and 24 years of age, attending the Teen Club HIV clinic at Kilimanjaro Christian Medical Centre (KCMC) and/or Mawenzi Hospital and receiving ART
  • if > or =l to 18 years, able to understand the project and provide written, informed consent
  • if \< 18 years, a parent or guardian must provide written permission and participant must be able to assent
  • all adolescents must also commit to attending 10 weekly CBT (SYV) sessions and 2 individual sessions.

Exclusion criteria

Exclusion Criteria:

  • Active psychosis, developmental delay, or cognitive disability that precludes active participation in consent process, intervention, and assessment interviews.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
140 participants (actual)

Study arms

  • Experimental
    Mental Health Intervention

    This arm was designed based on mental health needs of HIV-infected youth in Tanzania. It incorporates principles of cognitive behavioral therapy, interpersonal psychotherapy, and motivational interviewing built into 10 group sessions, approximately 90 minutes each (2 sessions with caregiver participation) and 2 individual sessions. Groups are age and gender matched and facilitated by lay counselors with a mix of lived experience and prior mental health research experience.

    Behavioral: Mental Health Intervention

  • Active comparator
    Standard of Care

    This arm includes standard medical care and adherence counseling with routine education prior to the start of the HIV youth clinic from which participants are recruited.

    Behavioral: Standard of Care

Interventions

  • BehavioralMental Health Intervention

    Includes a standard format of greetings, review of last session content, homework discussion, new topic, assigning homework and ends with a fun activity, relaxation or game. First session is a joint session with youth and caregivers. Topics include common stresses and worries experienced by HIV+ youth; relaxation and coping techniques; cognitive behavioral triangle; story of finding out HIV status and if willing, to discuss this in an individual session, peer group session, and with caregiver; identify circles of support; discuss stigma and how to disclose HIV status to others; consider values, hopes and dreams for the future, and how to use this information to live positively with HIV. ART adherence is woven into case examples and discussions.

  • BehavioralStandard of Care

    Standard of Care includes enhanced ART adherence based on clinic protocols and monthly HIV teaching sessions prior to adolescent clinic.

06

What researchers measure

Primary outcomes

  1. Participant attendance

    Measure the percentage of participants who complete all intervention sessions and ability to interview participants for outcome measures over time.

    Time frame: weekly for 16 weeks during each intervention wave (over 2 years)

  2. Caregiver participation as measured by questionnaire

    Record willingness of caregivers to participate (if unwilling, why not) and attendance.

    Time frame: during 2 caregiver sessions

  3. Caregiver participation as measured by attendance sheet

    Time frame: during 2 caregiver sessions

  4. Fidelity as measured by weekly supervisor meeting

    Time frame: weekly for 16 weeks during the intervention wave (over 2 years)

  5. Fidelity as measured by fidelity checklists

    Time frame: weekly for 16 weeks during the intervention wave (over 2 years)

Secondary outcomes

  1. Change in Mental Health

    Compare the change in standard deviation of mental health symptoms on the PHQ-9, between the intervention group versus SOC.

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

  2. Change in Mental Health

    Compare the change in standard deviation of mental health symptoms on the SDQ, between the intervention group versus SOC.

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

  3. Change in Mental Health

    Compare the change in standard deviation of mental health symptoms on the UCLA PTSD-RI, between the intervention group versus SOC.

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

  4. Change in ART adherence

    Compare the change in self-report adherence between the intervention group versus SOC.

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

  5. Change in virologic outcomes

    Describe the proportion of youth with viral suppression (HIV-1 RNA \< 400 copies/ml) in the intervention group and SOC.

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

  6. Compare method of adherence measurement

    Compare self-report ART adherence with drug level concentration of hair samples.

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

  7. Change in mental health (individual)

    Compare the change in standard deviation of mental health symptoms on the PHQ-9, SDQ, UCLA PTSD-RI at the individual level.

    Time frame: baseline to post-intervention, 6-, 12-,18- and 24-months

  8. Change in adherence (individual)

    Compare the change in self-reported adherence and antiretroviral drug concentration in hair.

    Time frame: baseline to post-intervention, 6-, 12-, and 24-months

  9. Change in HIV viral load (individual)

    Compare the change in HIV viral load.

    Time frame: baseline to post-intervention, 6-, 12-, and 24-months

07

Study locations

1 site
  • Kilimanjaro Christian Medical Centre
    Moshi, Tanzania
08

References and documents

Publications

  • Dow DE, Turner EL, Shayo AM, Mmbaga B, Cunningham CK, O'Donnell K. Evaluating mental health difficulties and associated outcomes among HIV-positive adolescents in Tanzania. AIDS Care. 2016 Jul;28(7):825-33. doi: 10.1080/09540121.2016.1139043. Epub 2016 Feb 3. PubMed 26837437 ↗
  • Ramaiya MK, Sullivan KA, O' Donnell K, Cunningham CK, Shayo AM, Mmbaga BT, Dow DE. A Qualitative Exploration of the Mental Health and Psychosocial Contexts of HIV-Positive Adolescents in Tanzania. PLoS One. 2016 Nov 16;11(11):e0165936. doi: 10.1371/journal.pone.0165936. eCollection 2016. PubMed 27851797 ↗
  • Gichane MW, Sullivan KA, Shayo AM, Mmbaga BT, O' Donnell K, Cunningham CK, Dow DE. Caregiver role in HIV medication adherence among HIV-infected orphans in Tanzania. AIDS Care. 2018 Jun;30(6):701-705. doi: 10.1080/09540121.2017.1391986. Epub 2017 Oct 23. PubMed 29058461 ↗
  • Dow DE, Mmbaga BT, Gallis JA, Turner EL, Gandhi M, Cunningham CK, O'Donnell KE. A group-based mental health intervention for young people living with HIV in Tanzania: results of a pilot individually randomized group treatment trial. BMC Public Health. 2020 Sep 4;20(1):1358. doi: 10.1186/s12889-020-09380-3. PubMed 32887558 ↗

Study documents

  • Informed consent form · Feb 1, 2015

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02888288
Lead sponsor
Duke University
Collaborators
Kilimanjaro Christian Medical Centre, Tanzania
Responsible party
Sponsor
First posted
Sep 5, 2016
Start date
Jul 2016
Primary completion
Aug 28, 2020
Completion
Aug 28, 2020
Last update
Oct 7, 2022

Study contacts

Dorothy E Dow, MD, MSc-GH
principal investigator · Duke University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion